ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 Update.

Autor:	Niell BL; Panel Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Electronic address: bethany.niell@moffitt.org., Jochelson MS; Memorial Sloan Kettering Cancer Center, New York, New York., Amir T; Memorial Sloan Kettering Cancer Center, New York, New York., Brown A; Panel Vice Chair, University of Cincinnati, Cincinnati, Ohio., Adamson M; Clinica Family Health, Lafayette, Colorado; American Academy of Family Physicians., Baron P; Lenox Hill Hospital, Northwell Health, New York, New York; American College of Surgeons., Bennett DL; Washington University School of Medicine, Saint Louis, Missouri., Chetlen A; Penn State Health Hershey Medical Center, Hershey, Pennsylvania., Dayaratna S; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania; American College of Obstetricians and Gynecologists., Freer PE; University of Utah, Salt Lake City, Utah., Ivansco LK; Kaiser Permanente, Atlanta, Georgia., Klein KA; University of Michigan, Ann Arbor, Michigan., Malak SF; St. Bernards Healthcare, Jonesboro, Arkansas., Mehta TS; UMass Memorial Medical Center/UMass Chan Medical School, Worcester, Massachusetts., Moy L; NYU Clinical Cancer Center, New York, New York., Neal CH; ProMedica Breast Care, Toledo, Ohio., Newell MS; Emory University Hospital, Atlanta, Georgia; RADS Committee., Richman IB; Yale School of Medicine, New Haven, Connecticut; Society of General Internal Medicine., Schonberg M; Harvard Medical School, Boston, Massachusetts; American Geriatrics Society., Small W Jr; Loyola University Chicago, Stritch School of Medicine, Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Maywood, Illinois; Commission on Radiation Oncology., Ulaner GA; Hoag Family Cancer Institute, Newport Beach, California; University of Southern California, Los Angeles, California; Commission on Nuclear Medicine and Molecular Imaging., Slanetz PJ; Specialty Chair, Boston University School of Medicine, Boston, Massachusetts.
Jazyk:	angličtina
Zdroj:	Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2024 Jun; Vol. 21 (6S), pp. S126-S143.
DOI:	10.1016/j.jacr.2024.02.019
Abstrakt:	Early detection of breast cancer from regular screening substantially reduces breast cancer mortality and morbidity. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual's risk of developing breast cancer. Numerous factors contribute to breast cancer risk, which is frequently divided into three major categories: average, intermediate, and high risk. For patients assigned female at birth with native breast tissue, mammography and digital breast tomosynthesis are the recommended method for breast cancer screening in all risk categories. In addition to the recommendation of mammography and digital breast tomosynthesis in high-risk patients, screening with breast MRI is recommended. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation. (Copyright © 2024 American College of Radiology. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu